in aplastic anemia patients , but not patients with leukemia , the incidence of thyroid hypofunction 5 years post-transplant was significantly higher ( p less than 0.001 ) in those receiving methotrexate alone ( 82 % ) as prophylaxis for graft-versus-host disease compared with those receiving a regimen of methotrexate , antithymocyte globulin and prednisone ( 16 % ) .
C0018133
graft-versus-host disease
C0032952
prednisone